APA (7th ed.) Citation

Petruzziello, C., Armuzzi, A., Kohn, A., D'Incà, R., Papi, C., Spina, L., . . . Pallone, F. (2013). P292 Clinical characteristics of inflammatory bowel disease may influence the cancer risk when using immunomodulators: Incident cases of cancer in a multicenter case-control study. Journal of Crohn's & Colitis, 7, S126. https://doi.org/10.1016/S1873-9946(13)60313-X

Chicago Style (17th ed.) Citation

Petruzziello, C., et al. "P292 Clinical Characteristics of Inflammatory Bowel Disease May Influence the Cancer Risk When Using Immunomodulators: Incident Cases of Cancer in a Multicenter Case-control Study." Journal of Crohn's & Colitis 7 (2013): S126. https://doi.org/10.1016/S1873-9946(13)60313-X.

MLA (9th ed.) Citation

Petruzziello, C., et al. "P292 Clinical Characteristics of Inflammatory Bowel Disease May Influence the Cancer Risk When Using Immunomodulators: Incident Cases of Cancer in a Multicenter Case-control Study." Journal of Crohn's & Colitis, vol. 7, 2013, p. S126, https://doi.org/10.1016/S1873-9946(13)60313-X.